The team at CMS exhibits broad expertise across a diverse range of matters, including the restructuring of licenses, joint projects between pharma companies and healthcare institutions, and pricing and reimbursement negotiations. Practice head Ellen Gielen is known for her vast regulatory expertise, particularly in relation to pricing and reimbursement as well as manufacturing and distribution mandates. Judith Kok maintains a regulatory-focused practice, advising on the handling and marketing of medical devices and biocides, while Gertie Lintjens primarily advises clients in the pharma and medical device industries on early access issues and R&D projects, in addition to advertising and transparency disputes.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

‘Our contacts at CMS NL differ from many other lawyers in that they deliver practically usable results. They point out potential risks, but at the same time commit to an outcome and don't leave us guessing. After the consultation, we are definitely smarter and know our options.’
‘Knowledgeable about our market environment, very pragmatic and able to translate legal means to business outcomes, easy to work with.’
‘Good and timely follow up, very collaborative and good overall communication.’
‘Ellen Gielen was very collaborative when working together, understood our request for understandable legal expertise for non -legal people. Excellent interactivity and communication skills. Very knowledgeable in the medtech industry.’
‘CMS' team offer a deep understanding of the legal specificities of the medical devices industry.’
‘Ellen Gielen stands out as an industry expert. She carefully listens and thinks along with clients in providing strategic and pragmatic advice.’